Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement

J Neuroimmunol. 2021 Jun 7;357:577627. doi: 10.1016/j.jneuroim.2021.577627. Online ahead of print.

ABSTRACT

In this consensus statement, we provide updated recommendations on multiple sclerosis (MS) management during the COVID-19 crisis and the post-pandemic period applicable to neurology services around the world. Statements/recommendations were generated based on available literature and the experience of 13 MS expert panelists using a modified Delphi approach online. The statements/recommendations give advice regarding implementation of telemedicine; use of disease-modifying therapies and management of MS relapses; management of people with MS at highest risk from COVID-19; management of radiological monitoring; use of remote pharmacovigilance; impact on MS research; implications for lowest income settings, and other key issues.

PMID:34139567 | DOI:10.1016/j.jneuroim.2021.577627